TAK-901


CAS No. : 934541-31-8

934541-31-8
Price and Availability of CAS No. : 934541-31-8
Size Price Stock
5mg $80 In-stock
10mg $130 In-stock
25mg $260 In-stock
50mg $420 In-stock
100mg $670 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-12201
M.Wt: 504.64
Formula: C28H32N4O3S
Purity: >98 %
Solubility: DMSO : 65 mg/mL (ultrasonic)
Introduction of 934541-31-8 :

TAK-901 is a multi-targeted aurora inhibitor with IC50s of 21 and 15 nM for aurora A and B, respectively. IC50 & Target:IC50: 21 nM (aurora A), 15 nM (aurora B), 1.2 nM (JAK3), 1.3 nM (Src), 2 nM (FGR), 5 nM (FLT3)[1] In Vitro:TAK-901 exhibits time-dependent, tight-binding inhibition of Aurora B, but not Aurora A[1].
TAK-901 suppresses histone H3 phosphorylation in a dose-dependent manner with an EC50 value of 0.16 μM in PC3 cells[1].
TAK-901 is a substrate of the P-glycoprotein (PgP) drug efflux pump, as shown by the decrease in EC50 from 38 nM in the uterine sarcoma MES-SA cells to more than 50 μM in drug-resistant MES-SA/Dx5 expressing high levels of PgP[1].
Cell line EC50 (μM)
A2780 0.085
A375 0.39
A498 0.2
A549 0.13
COLO205 0.11
DLD1 1.5
H226 0.11
H358 0.077
H460 0.81
HT29 0.062
MDA-MB-435S 0.12
MES-SA 0.043
MKN-45 0.16
PC3 0.19
IMR-90 0.088
In Vivo:TAK-901 (In A2780 and AML MV4-11 nude mice xenograft model) causeS tumor stasis for 30 days at 30 and 40 mg/kg/injection, respectively[1].

Your information is safe with us.